MONOTERAPIA CON VIGABATRIN IN SOGGETTI CON EPILESSIA PARZIALE DI NUOVA DIAGNOSI: RISULTATI PRELIMINARI DI UNO STUDIO COLLABORATIVO APERTO

Translated title of the contribution: Vigabatrin monotherapy in partial epilepsy: Preliminary results of a open collaborative study

M. R. De Feo, O. Mecarelli, M. G. Marciani, S. Striano, A. Ortenzi, G. Cerone, P. D'Alessandro, M. Onofri

Research output: Contribution to journalArticlepeer-review

Abstract

In 48 new diagnosed epileptic patients, affected by partial simple or complex seizures with or without secondary generalization, GVG was administered as unique drug at a mean dose of 29 mg/kg/day. Minimum follow-up was 3 months, maximum 12 months. In about 80% of the patients a disappearance or a reduction ≥50% of the seizure frequency was obtained, without significant differences between cryptogenic and symptomatic etiology, thoughout the whole period of observation. Side effects, mainly body weight increment, were usually mild and transitory.

Translated title of the contributionVigabatrin monotherapy in partial epilepsy: Preliminary results of a open collaborative study
Original languageItalian
Pages (from-to)81-82
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number86-87
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Vigabatrin monotherapy in partial epilepsy: Preliminary results of a open collaborative study'. Together they form a unique fingerprint.

Cite this